Identifying DNA Methylation Modules Associated with a Cancer by Probabilistic Evolutionary Learning

DNA methylation leads to inhibition of downstream gene expression. Recently, considerable studies have been made to determine the effects of DNA methylation on complex disease. However, further studies are necessary to find the multiple interactions of many DNA methylation sites and their association with cancer. Here, to assess DNA methylation modules potentially relevant to disease, we use an Estimation of Distribution Algorithm (EDA) to identify high-order interaction of DNA methylated sites (or modules) that are potentially relevant to disease. The method builds a probabilistic dependency model to produce a solution that is a set of discriminative methylation sites. The algorithm is applied to array- and sequencing-based high-throughput DNA methylation profiling datasets. The experimental results show that it is able to identify DNA methylation modules for cancer.

[1]  Jie Zhang,et al.  Pan-cancer analysis of frequent DNA co-methylation patterns reveals consistent epigenetic landscape changes in multiple cancers , 2017, BMC Genomics.

[2]  Byoung-Tak Zhang,et al.  Bayesian evolutionary hypergraph learning for predicting cancer clinical outcomes , 2014, J. Biomed. Informatics.

[3]  Alexander Mendiburu,et al.  A Distance-Based Ranking Model Estimation of Distribution Algorithm for the Flowshop Scheduling Problem , 2014, IEEE Transactions on Evolutionary Computation.

[4]  Byoung-Tak Zhang,et al.  Integrated analysis of genome-wide DNA methylation and gene expression profiles in molecular subtypes of breast cancer , 2013, Nucleic acids research.

[5]  Peter J. Fleming,et al.  On finding well-spread pareto optimal solutions by preference-inspired co-evolutionary algorithm , 2013, GECCO '13.

[6]  Vaidyanathan K. Jayaraman,et al.  Hybrid feature selection and peptide binding affinity prediction using an EDA based algorithm , 2013, 2013 IEEE Congress on Evolutionary Computation.

[7]  Xian-hong Liu,et al.  RNAi screening identifies KAT8 as a key molecule important for cancer cell survival. , 2013, International journal of clinical and experimental pathology.

[8]  Abdullah Al Mamun,et al.  Multi-Objective Optimization with Estimation of Distribution Algorithm in a Noisy Environment , 2013, Evolutionary Computation.

[9]  Byoung-Tak Zhang,et al.  A probabilistic coevolutionary biclustering algorithm for discovering coherent patterns in gene expression dataset , 2012, BMC Bioinformatics.

[10]  Martha L Slattery,et al.  MAP kinase genes and colon and rectal cancer. , 2012, Carcinogenesis.

[11]  Thomas Lengauer,et al.  Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues , 2012, Epigenetics.

[12]  S. Horvath,et al.  Aging effects on DNA methylation modules in human brain and blood tissue , 2012, Genome Biology.

[13]  S. Lipkin,et al.  Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis. , 2012, The Journal of clinical investigation.

[14]  Peter A. Jones Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[15]  Adam Kiezun,et al.  Exome sequencing and the genetic basis of complex traits , 2012, Nature Genetics.

[16]  R. Siebert,et al.  Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma , 2012, International journal of cancer.

[17]  A. Shukla,et al.  Structure Based Design and Synthesis of Peptide Inhibitor of Human LOX-12: In Vitro and In Vivo Analysis of a Novel Therapeutic Agent for Breast Cancer , 2012, PloS one.

[18]  H. Kitchener,et al.  The Dynamics and Prognostic Potential of DNA Methylation Changes at Stem Cell Gene Loci in Women's Cancer , 2012, PLoS genetics.

[19]  M. Esteller,et al.  Cancer epigenomics: beyond genomics. , 2012, Current opinion in genetics & development.

[20]  Dvir Aran,et al.  Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. , 2012, Human molecular genetics.

[21]  S. Dey,et al.  Evaluation of human LOX-12 as a serum marker for breast cancer. , 2011, Biochemical and biophysical research communications.

[22]  M. Jauberteau,et al.  Fine-Tuning Roles of Endogenous Brain-Derived Neurotrophic Factor, TrkB and Sortilin in Colorectal Cancer Cell Survival , 2011, PloS one.

[23]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[24]  Martin J. Aryee,et al.  A DNA hypermethylation module for the stem/progenitor cell signature of cancer , 2011, Genome research.

[25]  C. Ricketts,et al.  Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. , 2011, Cancer research.

[26]  Fiona M Ross,et al.  Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma. , 2011, Blood.

[27]  Manoj Kumar,et al.  Genetic Algorithm: Review and Application , 2010 .

[28]  Eleazar Eskin,et al.  Multi-marker tagging single nucleotide polymorphism selection using estimation of distribution algorithms , 2010, Artif. Intell. Medicine.

[29]  M. Esteller,et al.  Epigenetic modifications and human disease , 2010, Nature Biotechnology.

[30]  Jason I. Herschkowitz,et al.  Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer , 2010, Breast Cancer Research.

[31]  R. Siebert,et al.  DNA Methylation Profiles and Their Relationship with Cytogenetic Status in Adult Acute Myeloid Leukemia , 2010, PloS one.

[32]  Kalyanmoy Deb,et al.  A fast and accurate solution of constrained optimization problems using a hybrid bi-objective and penalty function approach , 2010, IEEE Congress on Evolutionary Computation.

[33]  M. Aoki,et al.  Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model , 2010, Proceedings of the National Academy of Sciences.

[34]  Brian C. Jackson,et al.  Update of human and mouse forkhead box (FOX) gene families , 2010, Human Genomics.

[35]  H. Lenz,et al.  Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer. , 2010, Gastroenterology.

[36]  P. Laird Principles and challenges of genome-wide DNA methylation analysis , 2010, Nature Reviews Genetics.

[37]  O. Rennert,et al.  Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer , 2010, British Journal of Cancer.

[38]  Y. Dou,et al.  Two mammalian MOF complexes regulate transcription activation by distinct mechanisms. , 2009, Molecular cell.

[39]  A. Jimeno,et al.  Characterizing DNA methylation patterns in pancreatic cancer genome , 2009, Molecular oncology.

[40]  Qingfu Zhang,et al.  Approximating the Set of Pareto-Optimal Solutions in Both the Decision and Objective Spaces by an Estimation of Distribution Algorithm , 2009, IEEE Transactions on Evolutionary Computation.

[41]  Per Kristian Lehre,et al.  When is an estimation of distribution algorithm better than an evolutionary algorithm? , 2009, 2009 IEEE Congress on Evolutionary Computation.

[42]  E. Lobenhofer,et al.  Comparative epigenomics of human and mouse mammary tumors , 2009, Genes, chromosomes & cancer.

[43]  Cornelia M van Duijn,et al.  Genome-based prediction of common diseases: advances and prospects. , 2008, Human molecular genetics.

[44]  L. Cantley,et al.  PI3K pathway alterations in cancer: variations on a theme , 2008, Oncogene.

[45]  J. Squire,et al.  Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer , 2008, Current genomics.

[46]  L. Bonetta Epigenomics: Detailed analysis , 2008, Nature.

[47]  L. Ellis,et al.  VEGF-targeted therapy: mechanisms of anti-tumour activity , 2008, Nature Reviews Cancer.

[48]  C. Shriver,et al.  Identification of a gene expression breast cancer nodal metastasis profile , 2008 .

[49]  N. Clarke,et al.  Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma , 2008, British Journal of Cancer.

[50]  Martin Pelikan,et al.  Dependency trees, permutations, and quadratic assignment problem , 2007, GECCO '07.

[51]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[52]  I. Tomlinson,et al.  Colorectal cancer and genetic alterations in the Wnt pathway , 2006, Oncogene.

[53]  S. Bandyopadhyay,et al.  Evolutionary computation in bioinformatics: a review , 2006, IEEE Transactions on Systems, Man, and Cybernetics, Part C (Applications and Reviews).

[54]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Ptak,et al.  Colorectal cancer: Mutations in a signalling pathway , 2005, Nature.

[56]  K. Robertson DNA methylation and human disease , 2005, Nature Reviews Genetics.

[57]  Jing-Yuan Fang,et al.  The MAPK signalling pathways and colorectal cancer. , 2005, The Lancet. Oncology.

[58]  G Milano,et al.  Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[59]  M. Daly,et al.  Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.

[60]  R. Roskoski The ErbB/HER receptor protein-tyrosine kinases and cancer. , 2004, Biochemical and biophysical research communications.

[61]  M. Dowsett,et al.  Circulating tumour cells in breast cancer. , 2004, The Lancet. Oncology.

[62]  K. Honn,et al.  Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression. , 2003, Cancer research.

[63]  K. Honn,et al.  Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. , 2002, Cancer research.

[64]  X. Ding,et al.  Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells. , 1999, Biochemical and biophysical research communications.

[65]  D. Grimm,et al.  Diagnostic and therapeutic use of membrane proteins in cancer cells. , 2011, Current medicinal chemistry.

[66]  Sreeram V Ramagopalan,et al.  Epigenetics: molecular mechanisms and implications for disease. , 2010, Trends in molecular medicine.

[67]  Arnaud Krebs,et al.  GPAT: Retrieval of genomic annotation from large genomic position datasets , 2008, BMC Bioinformatics.

[68]  K. Honn,et al.  Overexpression of Platelet-type 12-Lipoxygenase Promotes Tumor Cell Survival by Enhancing v 3 and v 5 Integrin Expression 1 , 2003 .